NICE (UK) recommends teclistamab as an option for treating relapsed and refractory multiple myeloma – Johnson & Johnson
NICE (UK) 1.1Teclistamab is recommended as an option for treating relapsed and refractory multiple myeloma in adults, only after 3 or more lines of treatment (including an immunomodulatory… read more.
